Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines. - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Molecular and Cellular Endocrinology Année : 2014

Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.

Résumé

Estrogen receptor alpha (ERα) is generally considered to be a good prognostic marker because almost 70% of ERα-positive tumors respond to anti-hormone therapies. Unfortunately, during cancer progression, mammary tumors can escape from estrogen control, resulting in resistance to treatment. In this study, we demonstrate that activation of the actin/megakaryoblastic leukemia 1 (MKL1) signaling pathway promotes the hormonal escape of estrogen-sensitive breast cancer cell lines. The actin/MKL1 signaling pathway is silenced in differentiated ERα-positive breast cancer MCF-7 and T47D cell lines and active in ERα-negative HMT-3522 T4-2 and MDA-MB-231 breast cancer cells, which have undergone epithelial-mesenchymal transition. We showed that MKL1 activation in MCF-7 cells, either by modulating actin dynamics or using MKL1 mutants, down-regulates ERα expression and abolishes E2-dependent cell growth. Interestingly, the constitutively active form of MKL1 represses PR and HER2 expression in these cells and increases the expression of HB-EGF, TGFβ, and amphiregulin growth factors in an E2-independent manner. The resulting expression profile (ER-, PR-, HER2-) typically corresponds to the triple-negative breast cancer expression profile.
Fichier principal
Vignette du fichier
Activation_of_the_MKL1actin_Kerdivel_et_al._text_Figures.pdf (6.47 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01061363 , version 1 (05-09-2014)

Identifiants

Citer

Gwenneg Kerdivel, Antoine Boudot, Denis Habauzit, Frederic Percevault, Florence Demay, et al.. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.. Molecular and Cellular Endocrinology, 2014, 390 (1-2), pp.34-44. ⟨10.1016/j.mce.2014.03.009⟩. ⟨hal-01061363⟩
301 Consultations
372 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More